nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—TRPV1—urinary bladder cancer	0.526	0.679	CbGaD
Icosapent—PPARG—urinary bladder cancer	0.175	0.225	CbGaD
Icosapent—PTGS2—urinary bladder cancer	0.0737	0.0952	CbGaD
Icosapent—PTGS2—Cisplatin—urinary bladder cancer	0.018	0.356	CbGbCtD
Icosapent—PTGS2—Etoposide—urinary bladder cancer	0.0176	0.349	CbGbCtD
Icosapent—PTGS1—Etoposide—urinary bladder cancer	0.0149	0.295	CbGbCtD
Icosapent—ACSL3—prostate gland—urinary bladder cancer	0.00578	0.0746	CbGeAlD
Icosapent—ACSL3—renal system—urinary bladder cancer	0.00394	0.0508	CbGeAlD
Icosapent—Alpha-Linolenic Acid—TRPV1—urinary bladder cancer	0.00376	0.845	CrCbGaD
Icosapent—SLC8A1—smooth muscle tissue—urinary bladder cancer	0.00339	0.0438	CbGeAlD
Icosapent—SLC8A1—renal system—urinary bladder cancer	0.00326	0.0421	CbGeAlD
Icosapent—FADS1—prostate gland—urinary bladder cancer	0.0032	0.0412	CbGeAlD
Icosapent—ACSL3—female reproductive system—urinary bladder cancer	0.00315	0.0407	CbGeAlD
Icosapent—ACSL4—prostate gland—urinary bladder cancer	0.0029	0.0375	CbGeAlD
Icosapent—PPARD—prostate gland—urinary bladder cancer	0.00279	0.036	CbGeAlD
Icosapent—FADS1—seminal vesicle—urinary bladder cancer	0.0027	0.0349	CbGeAlD
Icosapent—SLC8A1—female reproductive system—urinary bladder cancer	0.00261	0.0337	CbGeAlD
Icosapent—ACSL4—seminal vesicle—urinary bladder cancer	0.00245	0.0317	CbGeAlD
Icosapent—TRPV1—epithelium—urinary bladder cancer	0.00235	0.0303	CbGeAlD
Icosapent—FADS1—smooth muscle tissue—urinary bladder cancer	0.00226	0.0292	CbGeAlD
Icosapent—TRPV1—renal system—urinary bladder cancer	0.00218	0.0281	CbGeAlD
Icosapent—FADS1—urethra—urinary bladder cancer	0.00214	0.0276	CbGeAlD
Icosapent—ACSL4—renal system—urinary bladder cancer	0.00198	0.0255	CbGeAlD
Icosapent—ACSL4—urethra—urinary bladder cancer	0.00194	0.0251	CbGeAlD
Icosapent—FABP7—female reproductive system—urinary bladder cancer	0.00192	0.0248	CbGeAlD
Icosapent—PPARG—Teniposide—Etoposide—urinary bladder cancer	0.00191	1	CbGdCrCtD
Icosapent—TRPV1—female reproductive system—urinary bladder cancer	0.00174	0.0225	CbGeAlD
Icosapent—ACSL4—female reproductive system—urinary bladder cancer	0.00158	0.0204	CbGeAlD
Icosapent—FADS1—vagina—urinary bladder cancer	0.00158	0.0204	CbGeAlD
Icosapent—PPARD—female reproductive system—urinary bladder cancer	0.00152	0.0196	CbGeAlD
Icosapent—ACSL4—vagina—urinary bladder cancer	0.00143	0.0185	CbGeAlD
Icosapent—PPARD—vagina—urinary bladder cancer	0.00138	0.0178	CbGeAlD
Icosapent—PPARG—prostate gland—urinary bladder cancer	0.00131	0.0168	CbGeAlD
Icosapent—FADS1—lymph node—urinary bladder cancer	0.00102	0.0132	CbGeAlD
Icosapent—PPARG—epithelium—urinary bladder cancer	0.000959	0.0124	CbGeAlD
Icosapent—ACSL4—lymph node—urinary bladder cancer	0.000926	0.012	CbGeAlD
Icosapent—PPARG—smooth muscle tissue—urinary bladder cancer	0.000924	0.0119	CbGeAlD
Icosapent—PPARG—renal system—urinary bladder cancer	0.00089	0.0115	CbGeAlD
Icosapent—PPARD—lymph node—urinary bladder cancer	0.000889	0.0115	CbGeAlD
Icosapent—PPARG—urethra—urinary bladder cancer	0.000874	0.0113	CbGeAlD
Icosapent—PPARG—female reproductive system—urinary bladder cancer	0.000712	0.0092	CbGeAlD
Icosapent—PTGS1—prostate gland—urinary bladder cancer	0.000698	0.00901	CbGeAlD
Icosapent—Dihomo-gamma-linolenic acid—PTGS2—urinary bladder cancer	0.000687	0.155	CrCbGaD
Icosapent—PTGS2—prostate gland—urinary bladder cancer	0.000667	0.00861	CbGeAlD
Icosapent—PPARG—vagina—urinary bladder cancer	0.000644	0.00832	CbGeAlD
Icosapent—PTGS1—seminal vesicle—urinary bladder cancer	0.00059	0.00762	CbGeAlD
Icosapent—PTGS2—seminal vesicle—urinary bladder cancer	0.000564	0.00728	CbGeAlD
Icosapent—PTGS1—epithelium—urinary bladder cancer	0.000513	0.00662	CbGeAlD
Icosapent—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000494	0.00638	CbGeAlD
Icosapent—PTGS2—epithelium—urinary bladder cancer	0.00049	0.00633	CbGeAlD
Icosapent—PTGS1—renal system—urinary bladder cancer	0.000476	0.00614	CbGeAlD
Icosapent—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000472	0.0061	CbGeAlD
Icosapent—PTGS2—renal system—urinary bladder cancer	0.000455	0.00587	CbGeAlD
Icosapent—PTGS2—urethra—urinary bladder cancer	0.000447	0.00576	CbGeAlD
Icosapent—PPARG—lymph node—urinary bladder cancer	0.000417	0.00538	CbGeAlD
Icosapent—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.00041	0.0378	CcSEcCtD
Icosapent—PTGS1—female reproductive system—urinary bladder cancer	0.000381	0.00492	CbGeAlD
Icosapent—PTGS2—female reproductive system—urinary bladder cancer	0.000364	0.0047	CbGeAlD
Icosapent—PTGS1—vagina—urinary bladder cancer	0.000344	0.00445	CbGeAlD
Icosapent—PTGS2—vagina—urinary bladder cancer	0.000329	0.00425	CbGeAlD
Icosapent—Pruritus—Valrubicin—urinary bladder cancer	0.000318	0.0293	CcSEcCtD
Icosapent—Vomiting—Valrubicin—urinary bladder cancer	0.000286	0.0264	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Thiotepa—urinary bladder cancer	0.000285	0.0263	CcSEcCtD
Icosapent—Rash—Valrubicin—urinary bladder cancer	0.000283	0.0261	CcSEcCtD
Icosapent—Dermatitis—Valrubicin—urinary bladder cancer	0.000283	0.0261	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Thiotepa—urinary bladder cancer	0.000279	0.0258	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00024	0.0221	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.000235	0.0217	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Cisplatin—urinary bladder cancer	0.000224	0.0206	CcSEcCtD
Icosapent—PTGS1—lymph node—urinary bladder cancer	0.000223	0.00288	CbGeAlD
Icosapent—PTGS2—lymph node—urinary bladder cancer	0.000213	0.00275	CbGeAlD
Icosapent—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.000201	0.0185	CcSEcCtD
Icosapent—Vomiting—Mitomycin—urinary bladder cancer	0.000197	0.0182	CcSEcCtD
Icosapent—Rash—Mitomycin—urinary bladder cancer	0.000195	0.018	CcSEcCtD
Icosapent—Dermatitis—Mitomycin—urinary bladder cancer	0.000195	0.018	CcSEcCtD
Icosapent—Malnutrition—Thiotepa—urinary bladder cancer	0.000191	0.0176	CcSEcCtD
Icosapent—Eructation—Epirubicin—urinary bladder cancer	0.000173	0.0159	CcSEcCtD
Icosapent—Arthralgia—Thiotepa—urinary bladder cancer	0.000162	0.015	CcSEcCtD
Icosapent—Eructation—Doxorubicin—urinary bladder cancer	0.00016	0.0147	CcSEcCtD
Icosapent—Malnutrition—Cisplatin—urinary bladder cancer	0.00015	0.0138	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000142	0.0131	CcSEcCtD
Icosapent—Dyspepsia—Thiotepa—urinary bladder cancer	0.000137	0.0126	CcSEcCtD
Icosapent—Arthralgia—Gemcitabine—urinary bladder cancer	0.000137	0.0126	CcSEcCtD
Icosapent—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000134	0.0124	CcSEcCtD
Icosapent—Dysgeusia—Etoposide—urinary bladder cancer	0.000134	0.0124	CcSEcCtD
Icosapent—Constipation—Thiotepa—urinary bladder cancer	0.000133	0.0123	CcSEcCtD
Icosapent—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000131	0.0121	CcSEcCtD
Icosapent—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000129	0.0119	CcSEcCtD
Icosapent—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000122	0.0113	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000119	0.011	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000117	0.0108	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000115	0.0106	CcSEcCtD
Icosapent—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000113	0.0105	CcSEcCtD
Icosapent—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000113	0.0104	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000113	0.0104	CcSEcCtD
Icosapent—Constipation—Gemcitabine—urinary bladder cancer	0.000112	0.0103	CcSEcCtD
Icosapent—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000112	0.0103	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000111	0.0103	CcSEcCtD
Icosapent—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000111	0.0103	CcSEcCtD
Icosapent—Pruritus—Thiotepa—urinary bladder cancer	0.00011	0.0102	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000106	0.0098	CcSEcCtD
Icosapent—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000105	0.00972	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000104	0.0096	CcSEcCtD
Icosapent—Vomiting—Thiotepa—urinary bladder cancer	9.9e-05	0.00913	CcSEcCtD
Icosapent—Rash—Thiotepa—urinary bladder cancer	9.82e-05	0.00905	CcSEcCtD
Icosapent—Dermatitis—Thiotepa—urinary bladder cancer	9.81e-05	0.00904	CcSEcCtD
Icosapent—Gastrointestinal disorder—Etoposide—urinary bladder cancer	9.66e-05	0.0089	CcSEcCtD
Icosapent—Constipation—Etoposide—urinary bladder cancer	9.57e-05	0.00882	CcSEcCtD
Icosapent—Pruritus—Gemcitabine—urinary bladder cancer	9.27e-05	0.00855	CcSEcCtD
Icosapent—Pruritus—Fluorouracil—urinary bladder cancer	9.11e-05	0.0084	CcSEcCtD
Icosapent—Vomiting—Gemcitabine—urinary bladder cancer	8.33e-05	0.00768	CcSEcCtD
Icosapent—Rash—Gemcitabine—urinary bladder cancer	8.26e-05	0.00762	CcSEcCtD
Icosapent—Dermatitis—Gemcitabine—urinary bladder cancer	8.25e-05	0.00761	CcSEcCtD
Icosapent—Malnutrition—Methotrexate—urinary bladder cancer	8.21e-05	0.00757	CcSEcCtD
Icosapent—Vomiting—Fluorouracil—urinary bladder cancer	8.19e-05	0.00755	CcSEcCtD
Icosapent—Rash—Fluorouracil—urinary bladder cancer	8.12e-05	0.00749	CcSEcCtD
Icosapent—Dermatitis—Fluorouracil—urinary bladder cancer	8.11e-05	0.00748	CcSEcCtD
Icosapent—Dysgeusia—Methotrexate—urinary bladder cancer	8.04e-05	0.00741	CcSEcCtD
Icosapent—Pruritus—Etoposide—urinary bladder cancer	7.92e-05	0.0073	CcSEcCtD
Icosapent—Vomiting—Cisplatin—urinary bladder cancer	7.76e-05	0.00716	CcSEcCtD
Icosapent—Rash—Cisplatin—urinary bladder cancer	7.7e-05	0.0071	CcSEcCtD
Icosapent—Dermatitis—Cisplatin—urinary bladder cancer	7.69e-05	0.00709	CcSEcCtD
Icosapent—Malnutrition—Epirubicin—urinary bladder cancer	7.68e-05	0.00708	CcSEcCtD
Icosapent—Dysgeusia—Epirubicin—urinary bladder cancer	7.52e-05	0.00694	CcSEcCtD
Icosapent—Vomiting—Etoposide—urinary bladder cancer	7.11e-05	0.00656	CcSEcCtD
Icosapent—Malnutrition—Doxorubicin—urinary bladder cancer	7.11e-05	0.00655	CcSEcCtD
Icosapent—Rash—Etoposide—urinary bladder cancer	7.05e-05	0.0065	CcSEcCtD
Icosapent—Dermatitis—Etoposide—urinary bladder cancer	7.05e-05	0.0065	CcSEcCtD
Icosapent—Arthralgia—Methotrexate—urinary bladder cancer	6.99e-05	0.00644	CcSEcCtD
Icosapent—Dysgeusia—Doxorubicin—urinary bladder cancer	6.96e-05	0.00642	CcSEcCtD
Icosapent—Anaphylactic shock—Methotrexate—urinary bladder cancer	6.7e-05	0.00618	CcSEcCtD
Icosapent—Arthralgia—Epirubicin—urinary bladder cancer	6.54e-05	0.00603	CcSEcCtD
Icosapent—Anaphylactic shock—Epirubicin—urinary bladder cancer	6.27e-05	0.00578	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	6.11e-05	0.00563	CcSEcCtD
Icosapent—Arthralgia—Doxorubicin—urinary bladder cancer	6.05e-05	0.00558	CcSEcCtD
Icosapent—Dyspepsia—Methotrexate—urinary bladder cancer	5.9e-05	0.00544	CcSEcCtD
Icosapent—Anaphylactic shock—Doxorubicin—urinary bladder cancer	5.8e-05	0.00535	CcSEcCtD
Icosapent—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	5.79e-05	0.00533	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.71e-05	0.00527	CcSEcCtD
Icosapent—Dyspepsia—Epirubicin—urinary bladder cancer	5.52e-05	0.00509	CcSEcCtD
Icosapent—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	5.41e-05	0.00499	CcSEcCtD
Icosapent—Constipation—Epirubicin—urinary bladder cancer	5.36e-05	0.00494	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.29e-05	0.00487	CcSEcCtD
Icosapent—Dyspepsia—Doxorubicin—urinary bladder cancer	5.11e-05	0.00471	CcSEcCtD
Icosapent—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	5.01e-05	0.00462	CcSEcCtD
Icosapent—Constipation—Doxorubicin—urinary bladder cancer	4.96e-05	0.00457	CcSEcCtD
Icosapent—Pruritus—Methotrexate—urinary bladder cancer	4.74e-05	0.00437	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—RHOA—urinary bladder cancer	4.66e-05	0.000578	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	4.61e-05	0.000572	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.59e-05	0.000569	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PRSS3—urinary bladder cancer	4.54e-05	0.000563	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—KRAS—urinary bladder cancer	4.54e-05	0.000563	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—TNF—urinary bladder cancer	4.52e-05	0.00056	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.51e-05	0.000558	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	4.44e-05	0.00055	CbGpPWpGaD
Icosapent—Pruritus—Epirubicin—urinary bladder cancer	4.44e-05	0.00409	CcSEcCtD
Icosapent—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	4.43e-05	0.000549	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NCOR1—urinary bladder cancer	4.42e-05	0.000548	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	4.39e-05	0.000544	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	4.35e-05	0.000539	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—NCOR1—urinary bladder cancer	4.33e-05	0.000537	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	4.32e-05	0.000536	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—IL2—urinary bladder cancer	4.31e-05	0.000534	CbGpPWpGaD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	4.29e-05	0.000532	CbGpPWpGaD
Icosapent—Vomiting—Methotrexate—urinary bladder cancer	4.26e-05	0.00393	CcSEcCtD
Icosapent—Rash—Methotrexate—urinary bladder cancer	4.23e-05	0.0039	CcSEcCtD
Icosapent—Dermatitis—Methotrexate—urinary bladder cancer	4.22e-05	0.00389	CcSEcCtD
Icosapent—PTGS1—Metabolism—GSTO2—urinary bladder cancer	4.2e-05	0.00052	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NAT1—urinary bladder cancer	4.2e-05	0.00052	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PPARG—urinary bladder cancer	4.19e-05	0.000519	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.13e-05	0.000512	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—PTEN—urinary bladder cancer	4.12e-05	0.00051	CbGpPWpGaD
Icosapent—Pruritus—Doxorubicin—urinary bladder cancer	4.11e-05	0.00378	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—CXCL8—urinary bladder cancer	4.09e-05	0.000507	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NCOR1—urinary bladder cancer	4.08e-05	0.000505	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—TP53—urinary bladder cancer	4.04e-05	0.0005	CbGpPWpGaD
Icosapent—FADS1—Metabolism—CREBBP—urinary bladder cancer	4.02e-05	0.000499	CbGpPWpGaD
Icosapent—Vomiting—Epirubicin—urinary bladder cancer	3.99e-05	0.00368	CcSEcCtD
Icosapent—PTGS2—Disease—GSTO2—urinary bladder cancer	3.98e-05	0.000493	CbGpPWpGaD
Icosapent—Rash—Epirubicin—urinary bladder cancer	3.95e-05	0.00365	CcSEcCtD
Icosapent—Dermatitis—Epirubicin—urinary bladder cancer	3.95e-05	0.00364	CcSEcCtD
Icosapent—ACSL3—Metabolism—PTGS2—urinary bladder cancer	3.93e-05	0.000487	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—EP300—urinary bladder cancer	3.93e-05	0.000487	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL2—urinary bladder cancer	3.91e-05	0.000485	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	3.9e-05	0.000483	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TERT—urinary bladder cancer	3.9e-05	0.000483	CbGpPWpGaD
Icosapent—PPARD—Metabolism—NQO1—urinary bladder cancer	3.88e-05	0.00048	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—HRAS—urinary bladder cancer	3.86e-05	0.000479	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.84e-05	0.000476	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	3.84e-05	0.000476	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.83e-05	0.000474	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	3.82e-05	0.000474	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—NCOR1—urinary bladder cancer	3.82e-05	0.000474	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.81e-05	0.000472	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PPARG—urinary bladder cancer	3.79e-05	0.000469	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PPARG—urinary bladder cancer	3.79e-05	0.000469	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.76e-05	0.000466	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	3.73e-05	0.000462	CbGpPWpGaD
Icosapent—Vomiting—Doxorubicin—urinary bladder cancer	3.69e-05	0.0034	CcSEcCtD
Icosapent—Rash—Doxorubicin—urinary bladder cancer	3.66e-05	0.00337	CcSEcCtD
Icosapent—Dermatitis—Doxorubicin—urinary bladder cancer	3.66e-05	0.00337	CcSEcCtD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.64e-05	0.000451	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CREBBP—urinary bladder cancer	3.64e-05	0.000451	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CREBBP—urinary bladder cancer	3.64e-05	0.000451	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	3.63e-05	0.00045	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TYMP—urinary bladder cancer	3.63e-05	0.00045	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—ERCC2—urinary bladder cancer	3.59e-05	0.000445	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FGFR3—urinary bladder cancer	3.58e-05	0.000443	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	3.53e-05	0.000438	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	3.53e-05	0.000437	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	3.52e-05	0.000436	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.49e-05	0.000432	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ESR1—urinary bladder cancer	3.47e-05	0.00043	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	3.46e-05	0.000429	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	3.43e-05	0.000425	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PTEN—urinary bladder cancer	3.43e-05	0.000425	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—ESR1—urinary bladder cancer	3.4e-05	0.000422	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.34e-05	0.000414	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTO2—urinary bladder cancer	3.33e-05	0.000413	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NAT1—urinary bladder cancer	3.33e-05	0.000413	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.3e-05	0.000409	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PTGS2—urinary bladder cancer	3.3e-05	0.000408	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NAT2—urinary bladder cancer	3.29e-05	0.000407	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.28e-05	0.000406	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.28e-05	0.000406	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—EP300—urinary bladder cancer	3.27e-05	0.000405	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	3.27e-05	0.000405	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—MYC—urinary bladder cancer	3.24e-05	0.000402	CbGpPWpGaD
Icosapent—PPARD—Metabolism—GSTP1—urinary bladder cancer	3.23e-05	0.000401	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CDK4—urinary bladder cancer	3.22e-05	0.000399	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PRSS3—urinary bladder cancer	3.18e-05	0.000394	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.13e-05	0.000388	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SMC1A—urinary bladder cancer	3.1e-05	0.000384	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC19A1—urinary bladder cancer	3.1e-05	0.000384	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	3.05e-05	0.000378	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CREBBP—urinary bladder cancer	3.04e-05	0.000377	CbGpPWpGaD
Icosapent—PTGS2—Disease—PRSS3—urinary bladder cancer	3.02e-05	0.000374	CbGpPWpGaD
Icosapent—PPARD—Metabolism—TYMS—urinary bladder cancer	3.01e-05	0.000373	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IGF1—urinary bladder cancer	3.01e-05	0.000372	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	3e-05	0.000372	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—ESR1—urinary bladder cancer	3e-05	0.000372	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—EGFR—urinary bladder cancer	2.99e-05	0.000371	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—CREBBP—urinary bladder cancer	2.98e-05	0.00037	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PTGS2—urinary bladder cancer	2.98e-05	0.000369	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PTGS2—urinary bladder cancer	2.98e-05	0.000369	CbGpPWpGaD
Icosapent—PPARD—Metabolism—GSTM1—urinary bladder cancer	2.97e-05	0.000368	CbGpPWpGaD
Icosapent—PPARD—Metabolism—NCOR1—urinary bladder cancer	2.97e-05	0.000368	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	2.91e-05	0.000361	CbGpPWpGaD
Icosapent—PTGS2—Disease—HDAC4—urinary bladder cancer	2.88e-05	0.000357	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PTEN—urinary bladder cancer	2.87e-05	0.000356	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	2.85e-05	0.000353	CbGpPWpGaD
Icosapent—PPARD—Metabolism—GPX1—urinary bladder cancer	2.85e-05	0.000353	CbGpPWpGaD
Icosapent—PPARG—Metabolism—RRM2—urinary bladder cancer	2.84e-05	0.000351	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—KRAS—urinary bladder cancer	2.83e-05	0.00035	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TP53—urinary bladder cancer	2.81e-05	0.000348	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CREBBP—urinary bladder cancer	2.81e-05	0.000348	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.8e-05	0.000347	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ERCC2—urinary bladder cancer	2.79e-05	0.000346	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—RHOA—urinary bladder cancer	2.75e-05	0.000341	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	2.75e-05	0.00034	CbGpPWpGaD
Icosapent—FADS1—Metabolism—EP300—urinary bladder cancer	2.74e-05	0.00034	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—PPARG—urinary bladder cancer	2.74e-05	0.000339	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	2.71e-05	0.000336	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ESR2—urinary bladder cancer	2.7e-05	0.000335	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—CREBBP—urinary bladder cancer	2.63e-05	0.000326	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ENO2—urinary bladder cancer	2.63e-05	0.000325	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HPGDS—urinary bladder cancer	2.63e-05	0.000325	CbGpPWpGaD
Icosapent—PPARD—Metabolism—MTHFR—urinary bladder cancer	2.63e-05	0.000325	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PTEN—urinary bladder cancer	2.6e-05	0.000322	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PTEN—urinary bladder cancer	2.6e-05	0.000322	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	2.59e-05	0.000321	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.55e-05	0.000316	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ERBB2—urinary bladder cancer	2.55e-05	0.000316	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTT1—urinary bladder cancer	2.55e-05	0.000316	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TYMP—urinary bladder cancer	2.54e-05	0.000315	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—RHOA—urinary bladder cancer	2.54e-05	0.000315	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PRSS3—urinary bladder cancer	2.53e-05	0.000313	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.51e-05	0.000311	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—EP300—urinary bladder cancer	2.48e-05	0.000307	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—EP300—urinary bladder cancer	2.48e-05	0.000307	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.47e-05	0.000306	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.44e-05	0.000303	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCL8—urinary bladder cancer	2.42e-05	0.0003	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HRAS—urinary bladder cancer	2.4e-05	0.000298	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	2.39e-05	0.000297	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.39e-05	0.000296	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.39e-05	0.000296	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—ERBB2—urinary bladder cancer	2.35e-05	0.000291	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL2—urinary bladder cancer	2.31e-05	0.000286	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NAT2—urinary bladder cancer	2.3e-05	0.000285	CbGpPWpGaD
Icosapent—PTGS2—Disease—LIG1—urinary bladder cancer	2.29e-05	0.000283	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.27e-05	0.000282	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCND1—urinary bladder cancer	2.25e-05	0.000279	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.21e-05	0.000274	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MMP9—urinary bladder cancer	2.19e-05	0.000271	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.18e-05	0.00027	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PTEN—urinary bladder cancer	2.17e-05	0.000269	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PPARG—urinary bladder cancer	2.13e-05	0.000264	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NQO1—urinary bladder cancer	2.12e-05	0.000262	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—NCOR1—urinary bladder cancer	2.09e-05	0.000259	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EP300—urinary bladder cancer	2.07e-05	0.000257	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.05e-05	0.000255	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CREBBP—urinary bladder cancer	2.05e-05	0.000253	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.03e-05	0.000251	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TYMP—urinary bladder cancer	2.02e-05	0.00025	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP9—urinary bladder cancer	2.02e-05	0.00025	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SRC—urinary bladder cancer	2.02e-05	0.00025	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—RRM2—urinary bladder cancer	1.99e-05	0.000246	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.98e-05	0.000246	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ERCC2—urinary bladder cancer	1.96e-05	0.000243	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.94e-05	0.00024	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.94e-05	0.00024	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EP300—urinary bladder cancer	1.91e-05	0.000237	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—SRC—urinary bladder cancer	1.86e-05	0.00023	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.85e-05	0.000229	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ENO2—urinary bladder cancer	1.84e-05	0.000228	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HPGDS—urinary bladder cancer	1.84e-05	0.000228	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.83e-05	0.000227	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.83e-05	0.000227	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NAT2—urinary bladder cancer	1.83e-05	0.000226	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MYC—urinary bladder cancer	1.81e-05	0.000224	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.79e-05	0.000222	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTT1—urinary bladder cancer	1.78e-05	0.000221	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—MYC—urinary bladder cancer	1.77e-05	0.000219	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EGFR—urinary bladder cancer	1.77e-05	0.000219	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTP1—urinary bladder cancer	1.77e-05	0.000219	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.76e-05	0.000218	CbGpPWpGaD
Icosapent—PTGS2—Disease—ENO2—urinary bladder cancer	1.74e-05	0.000216	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.71e-05	0.000212	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTGS2—urinary bladder cancer	1.68e-05	0.000208	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KRAS—urinary bladder cancer	1.67e-05	0.000207	CbGpPWpGaD
Icosapent—PTGS2—Disease—RBX1—urinary bladder cancer	1.65e-05	0.000205	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TYMS—urinary bladder cancer	1.64e-05	0.000203	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ESR1—urinary bladder cancer	1.64e-05	0.000203	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EGFR—urinary bladder cancer	1.63e-05	0.000202	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.63e-05	0.000202	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTM1—urinary bladder cancer	1.62e-05	0.000201	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NCOR1—urinary bladder cancer	1.62e-05	0.000201	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—RRM2—urinary bladder cancer	1.58e-05	0.000195	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MYC—urinary bladder cancer	1.56e-05	0.000193	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GPX1—urinary bladder cancer	1.55e-05	0.000193	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—urinary bladder cancer	1.55e-05	0.000192	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KRAS—urinary bladder cancer	1.54e-05	0.000191	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ERCC2—urinary bladder cancer	1.53e-05	0.000189	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—urinary bladder cancer	1.48e-05	0.000184	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NQO1—urinary bladder cancer	1.48e-05	0.000184	CbGpPWpGaD
Icosapent—PTGS2—Disease—JAG1—urinary bladder cancer	1.48e-05	0.000183	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTEN—urinary bladder cancer	1.46e-05	0.000181	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ENO2—urinary bladder cancer	1.46e-05	0.000181	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HPGDS—urinary bladder cancer	1.46e-05	0.000181	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.45e-05	0.00018	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.44e-05	0.000178	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—CREBBP—urinary bladder cancer	1.44e-05	0.000178	CbGpPWpGaD
Icosapent—PPARG—Metabolism—MTHFR—urinary bladder cancer	1.43e-05	0.000178	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—urinary bladder cancer	1.42e-05	0.000176	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTT1—urinary bladder cancer	1.42e-05	0.000176	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.39e-05	0.000173	CbGpPWpGaD
Icosapent—PPARD—Metabolism—EP300—urinary bladder cancer	1.39e-05	0.000173	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HRAS—urinary bladder cancer	1.31e-05	0.000162	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.25e-05	0.000155	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.24e-05	0.000153	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.2e-05	0.000148	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.18e-05	0.000146	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.15e-05	0.000142	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.14e-05	0.000141	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.14e-05	0.000141	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CREBBP—urinary bladder cancer	1.12e-05	0.000138	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.09e-05	0.000135	CbGpPWpGaD
Icosapent—PTGS2—Disease—NCOR1—urinary bladder cancer	1.08e-05	0.000133	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	0.000132	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERCC2—urinary bladder cancer	1.01e-05	0.000126	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1e-05	0.000124	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.96e-06	0.000123	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTP1—urinary bladder cancer	9.82e-06	0.000122	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTHFR—urinary bladder cancer	9.52e-06	0.000118	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.5e-06	0.000118	CbGpPWpGaD
Icosapent—PTGS2—Disease—TERT—urinary bladder cancer	9.5e-06	0.000118	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTGS2—urinary bladder cancer	9.15e-06	0.000113	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TYMS—urinary bladder cancer	9.13e-06	0.000113	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NCOR1—urinary bladder cancer	9.02e-06	0.000112	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTM1—urinary bladder cancer	9.02e-06	0.000112	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGFR3—urinary bladder cancer	8.71e-06	0.000108	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GPX1—urinary bladder cancer	8.64e-06	0.000107	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MYC—urinary bladder cancer	8.53e-06	0.000106	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ERCC2—urinary bladder cancer	8.48e-06	0.000105	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPARG—urinary bladder cancer	8.15e-06	0.000101	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTEN—urinary bladder cancer	7.98e-06	9.88e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTHFR—urinary bladder cancer	7.97e-06	9.88e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CREBBP—urinary bladder cancer	7.83e-06	9.7e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—EP300—urinary bladder cancer	7.61e-06	9.43e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CREBBP—urinary bladder cancer	7.42e-06	9.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RHOA—urinary bladder cancer	6.71e-06	8.31e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPARG—urinary bladder cancer	6.47e-06	8.01e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTGS2—urinary bladder cancer	6.41e-06	7.94e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CREBBP—urinary bladder cancer	6.21e-06	7.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB2—urinary bladder cancer	6.21e-06	7.7e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTEN—urinary bladder cancer	5.59e-06	6.92e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—EP300—urinary bladder cancer	5.33e-06	6.6e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1A—urinary bladder cancer	5.31e-06	6.58e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PTEN—urinary bladder cancer	5.3e-06	6.56e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EP300—urinary bladder cancer	5.05e-06	6.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SRC—urinary bladder cancer	4.91e-06	6.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PTEN—urinary bladder cancer	4.44e-06	5.5e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MYC—urinary bladder cancer	4.4e-06	5.45e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGFR—urinary bladder cancer	4.31e-06	5.34e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—EP300—urinary bladder cancer	4.23e-06	5.24e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—KRAS—urinary bladder cancer	4.07e-06	5.04e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—urinary bladder cancer	3.46e-06	4.28e-05	CbGpPWpGaD
